Fevronia Angelatou
- Physiology top 1%
- Adenosine and Purinergic Signaling 11
-
- Neuroscience and Neuropharmacology Research 24
- Nerve injury and regeneration 8
- Developmental Neuroscience top 5%
- Neurogenesis and neuroplasticity mechanisms 5
- Psychiatry and Mental health top 5%
- Epilepsy research and treatment 8
- Biological Psychiatry top 10%
-
- Receptor Mechanisms and Signaling 8
- Ion channel regulation and function 5
-
- Neuroinflammation and Neurodegeneration Mechanisms 5
Fevronia Angelatou
38 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 91
- Physiology 296
- Cellular and Molecular Neuroscience 815
- Developmental Neuroscience 106
- Psychiatry and Mental health 233
- Biological Psychiatry 38
Countries citing papers authored by Fevronia Angelatou
This map shows the geographic impact of Fevronia Angelatou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fevronia Angelatou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fevronia Angelatou more than expected).
Fields of papers citing papers by Fevronia Angelatou
This network shows the impact of papers produced by Fevronia Angelatou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fevronia Angelatou. The network helps show where Fevronia Angelatou may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Fevronia Angelatou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 14 | |
| 2 | 2019 | 12 | |
| 3 | 2016 | 1 | |
| 4 | 2016 | 11 | |
| 5 | 2009 | 6 | |
| 6 | 2009 | 45 | |
| 7 | 2007 | 17 | |
| 8 | 2006 | 75 | |
| 9 | 2005 | 27 | |
| 10 | 2005 | 39 | |
| 11 | 2005 | 46 | |
| 12 | 2004 | 52 | |
| 13 | 2004 | 11 | |
| 14 | 2004 | 14 | |
| 15 | 2001 | 43 | |
| 16 | 2000 | 27 | |
| 17 | 2000 | 50 | |
| 18 | 1993 | 49 | |
| 19 | 1992 | 45 | |
| 20 | 1991 | 24 |
About Fevronia Angelatou
Fevronia Angelatou is a scholar working on Physiology, Cellular and Molecular Neuroscience and Developmental Neuroscience, having authored 38 papers that have together received 1.3k indexed citations. Recurring topics across this work include Neuroscience and Neuropharmacology Research (24 papers), Adenosine and Purinergic Signaling (11 papers), Nerve injury and regeneration (8 papers), Epilepsy research and treatment (8 papers), Receptor Mechanisms and Signaling (8 papers), Neuroinflammation and Neurodegeneration Mechanisms (5 papers), Ion channel regulation and function (5 papers) and Neurogenesis and neuroplasticity mechanisms (5 papers). The work is most often cited by research in Physiology (296 citations), Cellular and Molecular Neuroscience (815 citations) and Developmental Neuroscience (106 citations). Fevronia Angelatou has collaborated with scholars based in Greece, Bulgaria and Austria. Frequent co-authors include Nikolaos Matsokis, Olga Pagonopoulou, Antigoni Ekonomou, George Kostopoulos, Christos D. Georgiou, Nikolaos T. Panagopoulos, George Zervoudakis, Nikolaos Patsoukis, Costas Papatheodoropoulos and G. Kostopoulos. Their work appears in journals such as Neuroscience, Brain Research, Neurochemical Research, Neuroreport and Epilepsia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.